CV Sciences (QB) Stock Price

-0.005 (-0.79%)
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
CV Sciences Inc (QB) CVSI OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.005 -0.79% 0.625 16:33:03
Open Price Low Price High Price Close Price Prev Close
0.64 0.60 0.659 0.625 0.63
Bid Price Ask Price Spread News
0.60 0.639 0.039 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
737 1,321,671 $ 0.624124 $ 824,886 - 0.25 - 1.34
Last Trade Time Type Quantity Stock Price Currency
15:59:33 10,000 $ 0.625 USD

CV Sciences (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 63.90M 102.24M 91.82M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
1.02M $ - 0.00% - -

more financials information »

CV Sciences (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CVSI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.5770.6590.510.58290891,310,3340.0488.32%
1 Month0.53490.6590.460.53926221,009,8430.090116.84%
3 Months0.49950.740.3960.5441661872,4940.125525.13%
6 Months0.5490.890.3960.5575339583,5160.07613.84%
1 Year1.151.340.250.6553823742,202-0.525-45.65%
3 Years0.4459.200.252.991,232,9650.1840.45%
5 Years0.1359.200.112.35985,2200.49362.96%

CV Sciences (QB) Description

CV Sciences, Inc. operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors; and a pharmaceutical division focused on developing and commercializing CBD-based novel therapeutics. The Company's PlusCBD Oil consumer products are sold at more than 5,500 retail locations throughout the U.S. and it is the top-selling brand of hemp-derived CBD in the natural product retail market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. CV Sciences' state-of-the-art facility follows all guidelines for Good Manufacturing Practices (GMP) and the Company's hemp extracts are processed, produced, and tested throughout the manufacturing process to confirm purity and content to meet strict company quality standards. With a commitment to science, PlusCBD Oil's benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PlusCBD Oil was the first hemp-derived CBD supplement brand to invest in the scientific evidence necessary to achieve self-affirmed Generally Recognized as Safe (GRAS) status. The Company's pharmaceutical division focuses on developing and commercializing proprietary prescription drugs utilizing cannabidiol (CBD) as the active pharmaceutical ingredient. CV Sciences initial drug candidate (CVSI-007) combines CBD and nicotine, which the Company believes has the potential to effectively treat smokeless tobacco use and addiction. The market for cessation of smokeless tobacco use and addiction is estimated at greater than $2 billion.

Your Recent History
CV Science..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.